Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long NVO ETF

14.95
+0.12000.81%
Post-market: 15.000.0500+0.33%19:30 EDT
Volume:281.25K
Turnover:4.19M
Market Cap:38.69M
PE:- -
High:15.17
Open:15.07
Low:14.73
Close:14.83
52wk High:36.00
52wk Low:9.23
Shares:2.59M
Float Shares:2.59M
Volume Ratio:0.66
T/O Rate:10.87%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly on Novo Nordisk Lawsuit- "we Stand Firmly Behind Our Advertising"

THOMSON REUTERS
·
Jul 21

Eli Lilly Faces Lawsuit Over Weight-Loss Drug Ads! Accused By Novo Nordisk Of "Misleading Marketing"

Sector Pulse
·
Jul 21

U.S. Stocks on the Move-utz Brands, Tutor Perini, Tripadvisor

Reuters
·
Jul 21

Novo Nordisk Shares Dip 2% in Pre-Market Trading

Deep News
·
Jul 21

Novo Nordisk Shares Down 2% After Co Sues Lilly, Accusing it of False Advertising

THOMSON REUTERS
·
Jul 21

Eli Lilly Faces Legal Action from Novo Nordisk Over Alleged Misleading Weight-Loss Drug Advertisements

Stock News
·
Jul 21

Novo Nordisk Says Mismatched Diabetes Drug Ads Triggered Lawsuit Vs. Lilly

Dow Jones
·
Jul 21

Novo Nordisk files lawsuit against ‘misleading’ GLP-1 ads from Eli Lilly

TIPRANKS
·
Jul 21

Novo Nordisk Sues Eli Lilly Over Zepbound, Mounjaro Advertising

MT Newswires Live
·
Jul 21

Novo Nordisk Sues Eli Lilly Over Allegedly Misleading GLP-1 Advertising

MT Newswires Live
·
Jul 21

Novo Nordisk Sues Eli Lilly in U.S. Federal Court, Alleging Claim Under the Lanham Act, Court Records Show

THOMSON REUTERS
·
Jul 21

The world is desperate for weight-loss drugs. But Big Pharma can’t advertise them

CNN Business
·
Jul 21

Novo Nordisk price target raised to DKK 330 from DKK 290 at Citi

TIPRANKS
·
Jul 21

Novo Nordisk A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Jul 21

Update: Novo Nordisk's Wegovy Approved in India for Fatty Liver Disease Treatment

MT Newswires Live
·
Jul 20

Novo Nordisk (0QIU) Receives a Hold from Deutsche Bank

TIPRANKS
·
Jul 20

Novo Nordisk Guidance in Focus

Dow Jones
·
Jul 20

Trump's FDA May Soon Back Peptides. Should You Buy In?

Dow Jones
·
Jul 18

Novo Nordisk’s CagriSema Trial Wraps Up: What Completed Phase 3 Data Could Mean for NVO

TIPRANKS
·
Jul 18

Novo Nordisk to Launch Lower-cost Ozempic Copy in South Africa

Reuters
·
Jul 18